Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Invuity Inc.

www.invuity.com

Latest From Athenex Inc.

2017 IPOs In Review: US Biopharma Offerings Rise, Values Decline At Mid-Year

Nineteen biopharma firms went public in the US during the first half of 2017, but as the number of IPOs increased, the average return on first-time offerings decreased, raising a key question: can this pace of first-time offerings continue in the second half?

Commercial Financing

Deals Shaping The Medical Industry, July 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2017.

Deals BioPharmaceutical

Code Cart Crisis: Anatomy Of An Emergency Drug Shortage

How FDA, health care providers, and Pfizer and other drug makers are responding to a shortage of emergency medicines from the fragile, overstressed US sterile injectables sector.

Manufacturing Quality

Finance Watch: Summer Slowdown Begins Ahead Of BIO, But Two IPOs Launched

Athenex and Immuron launched IPOs in the US, but June has otherwise been a pretty quiet month for new biopharma financings – so far. The largest VC round so far this month is Checkmate's $27m Series B and the biggest public offering was conducted by CTI BioPharma, raising $45m.

Financing Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cancer
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Spotlight Surgical Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Invuity Inc.
  • Senior Management
  • Philip Sawyer, Pres. & CEO
    James Mackaness, CFO
    Alex Vayser, CTO
    Paul Davison, VP, R&D
    Doug Heigel, Vp, Ops
    Joe Guido, VP, Commercial Marketing & BD
    Steve Annen , VP, Product Management & Strategy
  • Contact Info
  • Invuity Inc.
    Phone: (415) 655-2100
    444 De Haro Street
    San Francisco, CA 94107
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register